Key result
Management of isolated type II endoleaks post-EVAR lacks high-quality evidence favoring conservative or early intervention.
This review underscores the ongoing debate and need for large, well-designed trials to determine the natural history and optimal management of type II endoleaks after EVAR.
Uncertainty in type II endoleak management after EVAR warrants individualized caution; leaves open optimal strategy pending RCTs.
Type II endoleaks are the most common endovascular complications of endovascular abdominal aortic aneurysm repair (EVAR); however, there has been a divided opinion regarding their significance in EVAR. Some advocate a conservative approach unless there is clear evidence of sac expansion, while others maintain early intervention is best to prevent adverse late outcomes such as rupture. There is a lack of level-one evidence in this challenging group of patients, and due to a low event rate of complications, large numbers of patients would be required in well-designed trials to fully understand the natural history of type II endoleak. This review will discuss the imaging, management, and outcome of patients with isolated type II endoleaks following infra-renal EVAR.
No takes yet. Share an insight, caveat, or question.
Sidloff et al. (2016) conducted a review in Type II endoleaks following infra-renal EVAR. Management of type II endoleaks was evaluated. Management of isolated type II endoleaks following infra-renal EVAR lacks level-one evidence, with divided opinions on conservative versus early intervention approaches.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: